MarketCap
Facebook
X
Telegram
Tyme Technologies Operativer Cashflow | TYME
Operativer Cashflow Jährlich Tyme Technologies
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -21.2 M | -23.6 M | -19.6 M | -20.1 M | -11.9 M | -5.86 M | -1.37 M | -6.61 M | -57.7 K | -47.5 K | -27.4 K | -100 |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -100 | -23.6 M | -9.2 M |
Operativer Cashflow Vierteljährlich Tyme Technologies
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.78 M | - | -14 M | -10.3 M | -5.81 M | - | -18.5 M | -12.8 M | -6.39 M | - | -13.9 M | -9.57 M | -5.6 M | - | -5.2 M | -4.7 M | -6.31 M | -5.2 M | -16.1 M | -10.9 M | - | - | - | -2.75 M | - | - | - | - | -1.37 M | - | - | -3.55 M | -1.94 M | - | -39.5 K | -25.2 K | -7.84 K | - | -19 K | -19 K | -7.27 K | - | -26 K | -12.9 K | -2.69 K | - | - | - | - |
Quartalsentwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -2.69 K | -18.5 M | -5.51 M |
Operativer Cashflow anderer Aktien in der Pharmaeinzelhändler
| Name | Operativer Cashflow | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Plus Therapeutics
PSTV
|
-20.8 M | - | - | $ 301 M |  USA |
 |
Pluristem Therapeutics
PSTI
|
-19.6 M | - | -1.9 % | $ 33.3 M |  Israel |
 |
Qualigen Therapeutics
QLGN
|
-6.95 M | - | 5.59 % | $ 1.16 M | USA |
 |
Qilian International Holding Group Limited
QLI
|
-2.37 M | - | -6.08 % | $ 184 M |  China |
 |
Cassava Sciences
SAVA
|
-32.3 M | - | - | $ 110 M | USA |
 |
Selecta Biosciences
SELB
|
-73.9 M | - | -8.69 % | $ 126 M | USA |
 |
Sangamo Therapeutics
SGMO
|
-97.2 M | - | - | $ 50.4 M | USA |
 |
Salarius Pharmaceuticals
SLRX
|
-4.83 M | - | - | $ 2.64 M | USA |
 |
Sensei Biotherapeutics
SNSE
|
-20.5 M | - | - | $ 17.5 M | USA |
 |
Sonnet BioTherapeutics Holdings
SONN
|
-12.8 M | - | - | $ 826 K | USA |
 |
Synthetic Biologics
SYN
|
-16.7 M | - | 1.32 % | $ 16.2 M | USA |
 |
Synlogic
SYBX
|
-4.36 M | - | - | $ 7.07 M | USA |
 |
Virios Therapeutics, LLC
VIRI
|
-15.6 M | - | 2710.01 % | $ 72.9 M | USA |
 |
Vallon Pharmaceuticals
VLON
|
-10.2 M | - | -6.47 % | $ 5.76 M | USA |
 |
Vaxart
VXRT
|
-2.05 M | - | -25.06 % | $ 46.3 M | USA |
 |
XOMA Corporation
XOMA
|
2.87 M | - | - | $ 485 M | USA |
 |
Repare Therapeutics
RPTX
|
-76.4 M | - | - | $ 112 M |  Canada |
 |
Sesen Bio
SESN
|
-59.9 M | - | 7.29 % | $ 127 M | USA |
|
Windtree Therapeutics
WINT
|
-15.4 M | - | - | $ 26.8 M | USA |
 |
Trean Insurance Group
TIG
|
109 M | - | - | $ 316 M | USA |
 |
SQZ Biotechnologies Company
SQZ
|
-83.5 M | - | 57.95 % | $ 12.8 M | USA |
 |
MEI Pharma
MEIP
|
-9.12 M | - | 10.43 % | $ 20.5 M | USA |
 |
Palatin Technologies
PTN
|
-13.5 M | - | - | $ 13 M | USA |
 |
Lyra Therapeutics
LYRA
|
-28.9 M | - | - | $ 24.9 M | USA |
 |
Brickell Biotech
BBI
|
-4.34 M | - | -5.38 % | $ 6.06 M | USA |
 |
Applied Therapeutics
APLT
|
-84.3 M | - | - | $ 8.42 M | USA |
 |
ESSA Pharma
EPIX
|
-22.7 M | - | - | $ 8.86 M | Canada |
 |
Generation Bio Co.
GBIO
|
-88.6 M | - | - | $ 344 M | USA |
 |
Clearside Biomedical
CLSD
|
-24.7 M | - | - | $ 25.3 M | USA |
 |
Merus N.V.
MRUS
|
-186 M | - | - | $ 5.78 B |  Niderland |
 |
RAPT Therapeutics
RAPT
|
-83.3 M | - | - | $ 2.36 B | USA |
 |
Annexon
ANNX
|
-186 M | $ 4.21 | 4.99 % | $ 653 M | USA |
 |
AbbVie
ABBV
|
19 B | $ 291.22 | 1.06 % | $ 515 B | USA |
 |
22nd Century Group
XXII
|
-7.72 M | $ 1.56 | -19.17 % | $ 287 K | USA |
 |
Axon Enterprise
AXON
|
211 M | $ 313.68 | -18.01 % | $ 24.5 B | USA |
 |
Biogen
BIIB
|
2.2 B | $ 248.51 | 1.88 % | $ 36.4 B | USA |
 |
BioLineRx Ltd.
BLRX
|
-8.07 M | $ 1.73 | -2.15 % | $ 4.26 B | Israel |
 |
Theratechnologies
THTX
|
2.38 M | - | - | $ 83.9 M | Canada |
 |
Exelixis
EXEL
|
884 M | $ 69.55 | 1.22 % | $ 18.9 B | USA |
 |
Geron Corporation
GERN
|
-111 M | $ 0.99 | 3.97 % | $ 660 M | USA |
 |
Gilead Sciences
GILD
|
10 B | $ 166.9 | -0.4 % | $ 208 B | USA |
 |
Grifols, S.A.
GRFS
|
902 M | $ 8.46 | -0.12 % | $ 5.75 B |  Spain |
 |
Alnylam Pharmaceuticals
ALNY
|
524 M | $ 155.97 | -0.44 % | $ 20.4 B | USA |
 |
InflaRx N.V.
IFRX
|
-35.3 M | $ 1.31 | -3.69 % | $ 88.1 M |  Germany |
 |
INmune Bio
INMB
|
-22.6 M | $ 1.12 | -4.68 % | $ 27.7 M | USA |
 |
Insmed Incorporated
INSM
|
-935 M | $ 114.55 | 5.32 % | $ 22.8 B | USA |